EUVIMEDEUVIMED entdecken
Crossref

Triple-Responsive Cross-Linked Micelles for Synergistic Chemo-Photothermal Cancer Therapy

Yaning Ou, Yudong Wang, Kanglin Chen, Wenxin Liao, Zhaomin Tang iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Yaning Ou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of New Energy and Materials, Southwest Petroleum University, Chengdu 610500, China. Hauptthemen laut MEDLINE: Micelles, Doxorubicin, Photothermal Therapy. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Fund Project of Sichuan Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have developed a novel triple-responsive (pH/reduction/near-infrared (NIR) light) cross-linked polymer micelle PEG-P(LL/LL-LA)-PCL-IR820 for enhanced synergistic cancer therapy. This micelle was synthesized using a triblock amphiphilic polymer based on polylysine, functionalized with maleic anhydride (LA) as a cross-linking site and polycaprolactone (PCL) for encapsulating the anticancer drug doxorubicin (DOX). The photosensitizer IR820 was grafted onto PCL to enable photothermal and photodynamic effects under NIR irradiation. The DOX-loaded cross-linked micelles (DCMs) demonstrated exceptional stability under physiological conditions, effectively preventing premature drug release. Rapid DOX release was triggered by the intracellular high glutathione (GSH) level and acidic pH in tumor cells. Under NIR irradiation, DCM micelles exhibited significant photothermal and photodynamic effects, which markedly enhanced the cytotoxicity against B16 tumor cells. In B16 tumor-bearing mice, the DCM-treated group achieved superior tumor growth inhibition and prolonged survival under NIR irradiation compared to un-cross-linked micelles (DUCM) or free DOX, with minimal systemic toxicity. The tumor volume in the DCM + NIR group was significantly inhibited compared with other groups, reaching only about 300 mm3 within 15 days, while for the PBS-treated group, it reached approximately 1400 mm3. The survival rate of the DCM + NIR group was also significantly higher, with an over 70% survival rate within a 40-day observation period. This work presents a robust nanoplatform that combines stability, microenvironment responsiveness, and multimodal therapy, offering a promising strategy for targeted cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesDoxorubicinPhotothermal TherapyAnimalsMiceCell Line, TumorDrug LiberationPolyestersPhotochemotherapyPhotosensitizing AgentsMice, Inbred C57BLPolymersHumansPolyethylene GlycolsDrug CarriersCross-Linking ReagentsMelanoma, ExperimentalFemaleAntineoplastic AgentsPolylysineIndocyanine Green

Stichwörter der Autor:innen

NIR responsivecross-linked structurepH/reduction dual responsivenesssynergistic therapy

Substanzen

MicellesDoxorubicinpolycaprolactonePolyestersPhotosensitizing AgentsPolymersPolyethylene GlycolsDrug CarriersCross-Linking ReagentsAntineoplastic Agents

Autor:innen und Institutionen

  • School of New Energy and Materials, Southwest Petroleum University, Chengdu 610500, China.

ORCID-Profile: Zhaomin Tang

Förderung

  • National Natural Science Foundation of China
  • Youth Fund Project of Sichuan Provincial Department of Science and Technology

Zitieren

APA

Ou, Y., Wang, Y., Chen, K., Liao, W., & Tang, Z. (2025). Triple-Responsive Cross-Linked Micelles for Synergistic Chemo-Photothermal Cancer Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01130

Vancouver

Ou Y, Wang Y, Chen K, Liao W, Tang Z. Triple-Responsive Cross-Linked Micelles for Synergistic Chemo-Photothermal Cancer Therapy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01130

BibTeX
@article{Ou2025,
  author = {Ou, Yaning and Wang, Yudong and Chen, Kanglin and Liao, Wenxin and Tang, Zhaomin},
  title = {Triple-Responsive Cross-Linked Micelles for Synergistic Chemo-Photothermal Cancer Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01130}
}
Kostenlos starten →